Literature DB >> 23811286

P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α.

Kevin H Liu1, Nhi Huynh, Oneel Patel, Arthur Shulkes, Graham Baldwin, Hong He.   

Abstract

P21 activated kinase 1 (PAK1) enhances colorectal cancer (CRC) progression by stimulating Wnt/β-catenin and Ras oncogene, which promote CRC survival via stimulation of hypoxia-inducible factor 1α (HIF-1α). The aim of this study was to assess the mechanism involved in the stimulation by PAK1 of CRC survival. PAK1 promoted CRC cell survival by up-regulation of HIF-1α. PAK1 was over-expressed and hyper-activated in tumors of ApcΔ(14/+) mice, which was correlated with over-expression of HIF-1α and β-catenin. Inhibition of PAK1 decreased tumor growth and the expression of HIF-1α and β-catenin in tumors of ApcΔ(14/+) mice, and suppressed xenograft tumor survival in SCID mice. These findings indicate that PAK1 stimulates CRC survival by up-regulation of HIF-1α.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CRC; HIF-1α; PAK1; β-Catenin

Mesh:

Substances:

Year:  2013        PMID: 23811286     DOI: 10.1016/j.canlet.2013.06.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.

Authors:  Shanshan Lin; Bo Zhu; Guozhi Huang; Qing Zeng; Chuhuai Wang
Journal:  Hum Cell       Date:  2018-11-30       Impact factor: 4.174

2.  Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway.

Authors:  Nhi Huynh; John A Beutler; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Biochim Biophys Acta       Date:  2014-10-22

3.  Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.

Authors:  Nhi Huynh; Arthur Shulkes; Graham Baldwin; Hong He
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

4.  Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.

Authors:  Jaudah Al-Maghrabi; Eman Emam; Wafaey Gomaa; Doaa Al-Qaydy; Basim Al-Maghrabi; Abdelbaset Buhmeida; Adel Abuzenadah; Mohammed Al-Qahtani; Mahmoud Al-Ahwal
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

5.  Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

Authors:  Chang-Yuan Wei; Qi-Xing Tan; Xiao Zhu; Qing-Hong Qin; Fei-Bai Zhu; Qin-Guo Mo; Wei-Ping Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  Republished: tracing PAKs from GI inflammation to cancer.

Authors:  Kyle Dammann; Vineeta Khare; Christoph Gasche
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

7.  A hypoxia-inducible factor 1α null splice variant lacking exon 10.

Authors:  Xiangyu Zhou; Weijia Zeng; Rui Peng; Hongyan Wang
Journal:  Cell Death Dis       Date:  2017-06-15       Impact factor: 8.469

8.  FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma.

Authors:  Jianjun Zhu; Shishan Deng; Jie Duan; Xingguo Xie; Shiquan Xu; Maocheng Ran; Xiaosi Dai; Yu Pu; Xiaoming Zhang
Journal:  Oncol Lett       Date:  2014-04-03       Impact factor: 2.967

9.  Demonstration and biological significance of a gastrin-P21-activated kinase 1 feedback loop in colorectal cancer cells.

Authors:  Nhi Huynh; Kevin H Liu; Mildred Yim; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Physiol Rep       Date:  2014-06-24

10.  FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine.

Authors:  Dannel Yeo; Hong He; Oneel Patel; Andrew M Lowy; Graham S Baldwin; Mehrdad Nikfarjam
Journal:  BMC Cancer       Date:  2016-01-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.